154 related articles for article (PubMed ID: 26116697)
1. Targeting HSP90 Ameliorates Nephropathy and Atherosclerosis Through Suppression of NF-κB and STAT Signaling Pathways in Diabetic Mice.
Lazaro I; Oguiza A; Recio C; Mallavia B; Madrigal-Matute J; Blanco J; Egido J; Martin-Ventura JL; Gomez-Guerrero C
Diabetes; 2015 Oct; 64(10):3600-13. PubMed ID: 26116697
[TBL] [Abstract][Full Text] [Related]
2. Heat shock protein 90 inhibitors attenuate inflammatory responses in atherosclerosis.
Madrigal-Matute J; López-Franco O; Blanco-Colio LM; Muñoz-García B; Ramos-Mozo P; Ortega L; Egido J; Martín-Ventura JL
Cardiovasc Res; 2010 May; 86(2):330-7. PubMed ID: 20154064
[TBL] [Abstract][Full Text] [Related]
3. Interplay between HSP90 and Nrf2 pathways in diabetes-associated atherosclerosis.
Lazaro I; Oguiza A; Recio C; Lopez-Sanz L; Bernal S; Egido J; Gomez-Guerrero C
Clin Investig Arterioscler; 2017; 29(2):51-59. PubMed ID: 28188022
[TBL] [Abstract][Full Text] [Related]
4. Peptide-based inhibition of IκB kinase/nuclear factor-κB pathway protects against diabetes-associated nephropathy and atherosclerosis in a mouse model of type 1 diabetes.
Oguiza A; Recio C; Lazaro I; Mallavia B; Blanco J; Egido J; Gomez-Guerrero C
Diabetologia; 2015 Jul; 58(7):1656-67. PubMed ID: 25982245
[TBL] [Abstract][Full Text] [Related]
5. Heat shock protein 90 inhibition by 17-DMAG attenuates abdominal aortic aneurysm formation in mice.
Qi J; Yang P; Yi B; Huo Y; Chen M; Zhang J; Sun J
Am J Physiol Heart Circ Physiol; 2015 Apr; 308(8):H841-52. PubMed ID: 25637544
[TBL] [Abstract][Full Text] [Related]
6. 17-Dimethylaminoethylamino-17-demethoxygeldanamycin attenuates inflammatory responses in experimental stroke.
Qi J; Han X; Liu HT; Chen T; Zhang JL; Yang P; Bo SH; Lu XT; Zhang J
Biol Pharm Bull; 2014; 37(11):1713-8. PubMed ID: 25366476
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of heat shock protein (molecular weight 90 kDa) attenuates proinflammatory cytokines and prevents lipopolysaccharide-induced liver injury in mice.
Ambade A; Catalano D; Lim A; Mandrekar P
Hepatology; 2012 May; 55(5):1585-95. PubMed ID: 22105779
[TBL] [Abstract][Full Text] [Related]
8. HSP90 inhibition by 17-DMAG attenuates oxidative stress in experimental atherosclerosis.
Madrigal-Matute J; Fernandez-Garcia CE; Gomez-Guerrero C; Lopez-Franco O; Muñoz-Garcia B; Egido J; Blanco-Colio LM; Martin-Ventura JL
Cardiovasc Res; 2012 Jul; 95(1):116-23. PubMed ID: 22547655
[TBL] [Abstract][Full Text] [Related]
9. HSP90 inhibition suppresses inflammatory response and reduces carotid atherosclerotic plaque formation in ApoE mice.
Mu H; Wang L; Zhao L
Cardiovasc Ther; 2017 Apr; 35(2):. PubMed ID: 28009484
[TBL] [Abstract][Full Text] [Related]
10. 17-DMAG targets the nuclear factor-kappaB family of proteins to induce apoptosis in chronic lymphocytic leukemia: clinical implications of HSP90 inhibition.
Hertlein E; Wagner AJ; Jones J; Lin TS; Maddocks KJ; Towns WH; Goettl VM; Zhang X; Jarjoura D; Raymond CA; West DA; Croce CM; Byrd JC; Johnson AJ
Blood; 2010 Jul; 116(1):45-53. PubMed ID: 20351313
[TBL] [Abstract][Full Text] [Related]
11. Hemin therapy improves kidney function in male streptozotocin-induced diabetic rats: role of the heme oxygenase/atrial natriuretic peptide/adiponectin axis.
Ndisang JF; Jadhav A
Endocrinology; 2014 Jan; 155(1):215-29. PubMed ID: 24140713
[TBL] [Abstract][Full Text] [Related]
12. Hsp90 Inhibition Reduces TLR5 Surface Expression and NF-
Na BH; Hoang TX; Kim JY
Biomed Res Int; 2018; 2018():4319369. PubMed ID: 29651431
[TBL] [Abstract][Full Text] [Related]
13. HSP90 inhibition by 17-DMAG reduces inflammation in J774 macrophages through suppression of Akt and nuclear factor-κB pathways.
Shimp SK; Parson CD; Regna NL; Thomas AN; Chafin CB; Reilly CM; Nichole Rylander M
Inflamm Res; 2012 May; 61(5):521-33. PubMed ID: 22327510
[TBL] [Abstract][Full Text] [Related]
14. The apoptotic effect and associated signalling of HSP90 inhibitor 17-DMAG in hepatocellular carcinoma cells.
Leng AM; Liu T; Yang J; Cui JF; Li XH; Zhu YN; Xiong T; Zhang G; Chen Y
Cell Biol Int; 2012 Oct; 36(10):893-9. PubMed ID: 22694478
[TBL] [Abstract][Full Text] [Related]
15. Targeted cancer therapy through 17-DMAG as an Hsp90 inhibitor: Overview and current state of the art.
Mellatyar H; Talaei S; Pilehvar-Soltanahmadi Y; Barzegar A; Akbarzadeh A; Shahabi A; Barekati-Mowahed M; Zarghami N
Biomed Pharmacother; 2018 Jun; 102():608-617. PubMed ID: 29602128
[TBL] [Abstract][Full Text] [Related]
16. Suppressors of cytokine signaling abrogate diabetic nephropathy.
Ortiz-Muñoz G; Lopez-Parra V; Lopez-Franco O; Fernandez-Vizarra P; Mallavia B; Flores C; Sanz A; Blanco J; Mezzano S; Ortiz A; Egido J; Gomez-Guerrero C
J Am Soc Nephrol; 2010 May; 21(5):763-72. PubMed ID: 20185635
[TBL] [Abstract][Full Text] [Related]
17. 17-DMAG, an HSP90 Inhibitor, Ameliorates Multiple Organ Dysfunction Syndrome via Induction of HSP70 in Endotoxemic Rats.
Wang YL; Shen HH; Cheng PY; Chu YJ; Hwang HR; Lam KK; Lee YM
PLoS One; 2016; 11(5):e0155583. PubMed ID: 27224288
[TBL] [Abstract][Full Text] [Related]
18. Geldanamycin derivative ameliorates high fat diet-induced renal failure in diabetes.
Zhang HM; Dang H; Kamat A; Yeh CK; Zhang BX
PLoS One; 2012; 7(3):e32746. PubMed ID: 22412919
[TBL] [Abstract][Full Text] [Related]
19. Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway.
Ji X; Li C; Ou Y; Li N; Yuan K; Yang G; Chen X; Yang Z; Liu B; Cheung WW; Wang L; Huang R; Lan T
Mol Cell Endocrinol; 2016 Dec; 437():268-279. PubMed ID: 27378149
[TBL] [Abstract][Full Text] [Related]
20. NLRC5 deficiency ameliorates diabetic nephropathy through alleviating inflammation.
Luan P; Zhuang J; Zou J; Li H; Shuai P; Xu X; Zhao Y; Kou W; Ji S; Peng A; Xu Y; Su Q; Jian W; Peng W
FASEB J; 2018 Feb; 32(2):1070-1084. PubMed ID: 29070585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
